News / Blog

 

 

News/Blog

Count Me In

Count Me In

Funding from the National Cancer Institute will help optimize patient engagement in research while studying osteosarcoma and leiomyosarcoma The Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute, and Count Me In, a non-profit research initiative that...

read more

Tumor Testing

In many adult cancers, at diagnosis, a biopsy of the tumor is done and some of the tumor tissue is sent off for genetic testing. Then, depending on the results of the genetic testing, a particular treatment is chosen by the doctor. For Osteosarcoma there is only one...

read more

Germline Testing

When a child is diagnosed with osteosarcoma very young (typically below the age of 10) or has a strong family history of sarcomas/breast cancer/GBM, or when a patient relapses, genetic testing may be mentioned. There are two distinct types of genetic testing looking...

read more

Subscribe to Updates & News